Outcome evaluation in pre-trastuzumab era between different breast cancer phenotypes: a population-based study on Italian women.

doi:10.1177/030089161209800611

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Outcome evaluation in pre-trastuzumab era between different breast cancer phenotypes: a population-based study on Italian women.

Tumori - 1 Nov 2012

Cortesi Laura, De Matteis Elisabetta, Cirilli Claudia, Marcheselli Luigi, Proietto Manuela, Federico Massimo

Abstract excerpt

AIMS AND BACKGROUND: Based on estrogen receptor (ER), progesterone receptor (PgR) and Her2/neu (HER2) expression, four breast cancer subtypes have been distinguished: luminal A (ER and/or PgR/HER2-, Ki67 <14%), luminal B (ER and/or PgR/HER2-, Ki67 ≥14% or ER and/or PgR/HER2), triple-negative (ER-...

Topics

Adult
Biomarkers, Tumor
Breast Neoplasms
Carcinoma
Cohort Studies
Disease-Free Survival
Female
Humans
Italy
Kaplan-Meier Estimate
Ki-67 Antigen
Middle Aged
Multivariate Analysis
Neoplasm Staging
Phenotype
Predictive Value of Tests
Prognosis
Proportional Hazards Models

Source

Open in PubMed

Identifiers

PMID: 23389361
DOI: 10.1177/030089161209800611

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-23389361-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics